Home Patenting/Legal

Patenting/Legal

Latest
Patenting/Legal

UC, University of Vienna, Charpentier Granted Third European CRISPR Patent

Patenting/Legal

University of California and Partners Awarded Third U.S. CRISPR-Cas9 Patent

Patenting/Legal

MilliporeSigma to Be Awarded First U.S. CRISPR Patent

Patenting/Legal

OPKO Health, CEO and Chairman Agree to Pay $5.6M to Settle...

Gavel and sound bock in front of hammer
Patenting/Legal

Burrill Sentenced to 30-Month Prison Term on Fraud, Tax Evasion Charges

Insys Therapeutics says it will ponder its next steps following FDA rejection of its new drug application (NDA) for Buvaya (buprenorphine sublingual spray) as a treatment for moderate-to-severe acute pain.
Patenting/Legal

Insys Weighs Next Steps after FDA Rejects NDA for Acute Pain...

The Regents of the University of California (UC)
Patenting/Legal

UCal and Partners Win U.S. Patent Related to CRISPR-Cas9

Patenting/Legal

PixarBio CEO, Two Associates Face Federal Fraud Charges

Source: ©sergign/Fotolia
Patenting/Legal

Federal Circuit Favors Novartis’ Sandoz over Amgen in Biosimilar “Patent Dance”...

Patenting/Legal

Caris Life Sciences Files Patent Infringement Suit vs. Foundation Medicine

Load more

Recently Featured

Stay Connected

556,577FansLike
47,437FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up